The problem
China’s best hospitals drown in walk-in demand: patients travel across provinces and queue from dawn for a specialist number, while follow-up care means repeating the whole ordeal in person.
How it works
WeDoctor began as an online registration system for in-person hospital visits and grew into an internet-hospital and health-maintenance platform: patients book appointments, consult licensed doctors online, and subscribe to health-management memberships, with services surfaced inside WeChat through its strategic cooperation with Tencent. The company says it connects 11,500 medical institutions and 320,000 doctors.
Pain points
Ticket queues and scalpers for top hospitals, wasted travel for routine consultations, no continuity between visits, and employers and insurers lacking a digital front door to care.
Business model
Platform services for digital care plus health-management memberships — the segment that has driven total revenue growth since 2022 — with insurance and pharmaceutical businesses alongside; a planned spin-off would list the healthcare and technology divisions.
Challenges
Losses (RMB 1.9B in 2020) and Beijing’s private-sector crackdown killed its 2021 listing attempt; the core digital platform grows slowly while memberships carry the numbers; and JD Health and AliHealth, both already listed in Hong Kong, fight it on users and revenue rankings.
Funding
- Raised: $500M pre-IPO financing closed May 2018, led by AIA and NWS Holdings, at a reported $5.5B valuation.
- IPO attempts: prospectus filed April 2021 targeting up to $3B (36Kr via KrASIA); revived December 2024 targeting $400–500M by mid-2025.
Latest — Dec 2024
On 2 December 2024 sources told the South China Morning Post that Tencent-backed WeDoctor had revived its Hong Kong listing plan, aiming to file by end-December and complete the IPO by June 2025 to raise $400–500M after its 2021 attempt was disrupted by regulation.